Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.

ABSTRACT:

Background and objectives

Although most patients receiving maintenance dialysis exhibit initial seroresponse to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, concerns exist regarding the durability of this antibody response. This study evaluated seroresponse over time.

Design, setting, participants, & measurements

This retrospective cohort study included patients on maintenance dialysis, from a midsize national dialysis provider, who received a complete SARS-CoV-2 vaccine series and had at least one antibody titer checked after full vaccination. IgG spike antibodies (anti-spike IgG) titers were assessed monthly with routine laboratory tests after vaccination; the semiquantitative assay reported a range between zero and ≥20 Index. Descriptive analy

SUBMITTER: Hsu CM 

PROVIDER: S-EPMC8975038 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature